1.Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
Jie-Eun LEE ; Seung Hee YU ; Sung Rae KIM ; Kyu Jeung AHN ; Kee-Ho SONG ; In-Kyu LEE ; Ho-Sang SHON ; In Joo KIM ; Soo LIM ; Doo-Man KIM ; Choon Hee CHUNG ; Won-Young LEE ; Soon Hee LEE ; Dong Joon KIM ; Sung-Rae CHO ; Chang Hee JUNG ; Hyun Jeong JEON ; Seung-Hwan LEE ; Keun-Young PARK ; Sang Youl RHEE ; Sin Gon KIM ; Seok O PARK ; Dae Jung KIM ; Byung Joon KIM ; Sang Ah LEE ; Yong-Hyun KIM ; Kyung-Soo KIM ; Ji A SEO ; Il Seong NAM-GOONG ; Chang Won LEE ; Duk Kyu KIM ; Sang Wook KIM ; Chung Gu CHO ; Jung Han KIM ; Yeo-Joo KIM ; Jae-Myung YOO ; Kyung Wan MIN ; Moon-Kyu LEE
Diabetes & Metabolism Journal 2024;48(4):730-739
Background:
It is well known that a large number of patients with diabetes also have dyslipidemia, which significantly increases the risk of cardiovascular disease (CVD). This study aimed to evaluate the efficacy and safety of combination drugs consisting of metformin and atorvastatin, widely used as therapeutic agents for diabetes and dyslipidemia.
Methods:
This randomized, double-blind, placebo-controlled, parallel-group and phase III multicenter study included adults with glycosylated hemoglobin (HbA1c) levels >7.0% and <10.0%, low-density lipoprotein cholesterol (LDL-C) >100 and <250 mg/dL. One hundred eighty-five eligible subjects were randomized to the combination group (metformin+atorvastatin), metformin group (metformin+atorvastatin placebo), and atorvastatin group (atorvastatin+metformin placebo). The primary efficacy endpoints were the percent changes in HbA1c and LDL-C levels from baseline at the end of the treatment.
Results:
After 16 weeks of treatment compared to baseline, HbA1c showed a significant difference of 0.94% compared to the atorvastatin group in the combination group (0.35% vs. −0.58%, respectively; P<0.0001), whereas the proportion of patients with increased HbA1c was also 62% and 15%, respectively, showing a significant difference (P<0.001). The combination group also showed a significant decrease in LDL-C levels compared to the metformin group (−55.20% vs. −7.69%, P<0.001) without previously unknown adverse drug events.
Conclusion
The addition of atorvastatin to metformin improved HbA1c and LDL-C levels to a significant extent compared to metformin or atorvastatin alone in diabetes and dyslipidemia patients. This study also suggested metformin’s preventive effect on the glucose-elevating potential of atorvastatin in patients with type 2 diabetes mellitus and dyslipidemia, insufficiently controlled with exercise and diet. Metformin and atorvastatin combination might be an effective treatment in reducing the CVD risk in patients with both diabetes and dyslipidemia because of its lowering effect on LDL-C and glucose.
2.Projections of Demand for Cardiovascular Surgery and Supply of Surgeons.
Jung Jeung LEE ; Nam Hee PARK ; Kun Sei LEE ; Hyun Keun CHEE ; Sung Bo SIM ; Myo Jeong KIM ; Ji Suk CHOI ; Myunghwa KIM ; Choon Seon PARK
The Korean Journal of Thoracic and Cardiovascular Surgery 2016;49(Suppl 1):S37-S43
BACKGROUND: While demand for cardiovascular surgery is expected to increase gradually along with the rapid increase in cardiovascular diseases with respect to the aging population, the supply of thoracic and cardiovascular surgeons has been continuously decreasing over the past 10 years. Consequently, this study aims to achieve guidance in establishing health care policy by analyzing the supply and demand for cardiovascular surgeries in the medical service area of Korea. METHODS: After investigating the actual number of cardiovascular surgeries performed using the National Health Insurance claim data of the Health Insurance Review and Assessment Service, as well as drawing from national statistics concerning the elderly population aged 65 and over, this study estimated the number of future cardiovascular surgeries by using a cell-based model. To be able to analyze the supply and demand of surgeons, the recent status of new surgeons specializing in thoracic and cardiovascular surgeries and the ratio of their subspecialties in cardiovascular surgeries were investigated. Then, while taking three different scenarios into account, the number of cardiovascular surgeons expected be working in 5-year periods was projected. RESULTS: The number of cardiovascular surgeries, which was recorded at 10,581 cases in 2014, is predicted to increase consistently to reach a demand of 15,501 cases in 2040—an increase of 46.5%. There was a total of 245 cardiovascular surgeons at work in 2014. Looking at 5 year spans in the future, the number of surgeons expected to be supplied in 2040 is 184, to retire is 249, and expected to be working is 309—an increase of −24.9%, 1.6%, and 26.1%, respectively compared to those in 2014. This forecasts a demand-supply imbalance in every scenario. CONCLUSION: Cardiovascular surgeons are the most central resource in the medical service of highly specialized cardiovascular surgeries, and fostering the surgeons requires much time, effort, and resources; therefore, by analyzing the various factors affecting the supply of cardiovascular surgeons, an active intervention of policies can be prescribed for the areas that have failed to meet the appropriate market distributions.
Aged
;
Aging
;
Cardiovascular Diseases
;
Delivery of Health Care
;
Economics, Medical
;
Foster Home Care
;
Health Policy
;
Health Services Needs and Demand
;
Humans
;
Insurance, Health
;
Korea
;
National Health Programs
;
Surgeons*
;
Thoracic Surgery
3.A clinicogenetic model to predict lymph node invasion by use of genome-based biomarkers from exome arrays in prostate cancer patients.
Jong Jin OH ; Seunghyun PARK ; Sang Eun LEE ; Sung Kyu HONG ; Sangchul LEE ; Hak Min LEE ; Jeung Keun LEE ; Jin Nyoung HO ; Sungroh YOON ; Seok Soo BYUN
Korean Journal of Urology 2015;56(2):109-116
PURPOSE: Genetic variations among prostate cancer (PCa) patients who underwent radical prostatectomy (RP) and pelvic lymph node dissection were evaluated to predict lymph node invasion (LNI). Exome arrays were used to develop a clinicogenetic model that combined clinical data related to PCa and individual genetic variations. MATERIALS AND METHODS: We genotyped 242,186 single-nucleotide polymorphisms (SNPs) by using a custom HumanExome BeadChip v1.0 (Illumina Inc.) from the blood DNA of 341 patients with PCa. The genetic data were analyzed to calculate an odds ratio as an estimate of the relative risk of LNI. We compared the accuracies of the multivariate logistic model incorporating clinical factors between the included and excluded selected SNPs. The Cox proportional hazard models with or without genetic factors for predicting biochemical recurrence (BCR) were analyzed. RESULTS: The genetic analysis indicated that five SNPs (rs75444444, rs8055236, rs2301277, rs9300039, and rs6908581) were significant for predicting LNI in patients with PCa. When a multivariate model incorporating clinical factors was devised to predict LNI, the predictive accuracy of the multivariate model was 80.7%. By adding genetic factors in the aforementioned multivariate model, the predictive accuracy increased to 93.2% (p=0.006). These genetic variations were significant factors for predicting BCR after adjustment for other variables and after adding the predictive gain to BCR. CONCLUSIONS: Based on the results of the exome array, the selected SNPs were predictors for LNI. The addition of individualized genetic information effectively enhanced the predictive accuracy of LNI and BCR among patients with PCa who underwent RP.
Aged
;
Biomarkers, Tumor/*genetics
;
Biopsy
;
DNA, Neoplasm/genetics
;
Exome
;
Gene Frequency
;
Genome
;
Genotype
;
Humans
;
Lymph Node Excision
;
Lymph Nodes/pathology
;
Lymphatic Metastasis
;
Male
;
Middle Aged
;
*Models, Genetic
;
Neoplasm Invasiveness
;
Polymorphism, Single Nucleotide
;
Predictive Value of Tests
;
Prospective Studies
;
Prostatectomy
;
Prostatic Neoplasms/*genetics/pathology/surgery
4.Safety and Efficacy of Modern Insulin Analogues.
Hye Jin YOO ; Keun Yong PARK ; Kang Seo PARK ; Kyu Jeung AHN ; Kyung Wan MIN ; Jeong Hyun PARK ; Sang Ah CHANG ; Bong Soo CHA ; Dong Jun KIM ; Yong Seong KIM ; Tae Keun OH ; Suk CHON ; Il Seong NAM-GOONG ; Mi Jin KIM ; Hye Soon KIM ; Young Sik CHOI ; You Hern AHN ; Sora LEE ; Sei Hyun BAIK
Diabetes & Metabolism Journal 2013;37(3):181-189
BACKGROUND: A1chieve(R) was a noninterventional study evaluating the clinical safety and efficacy of biphasic insulin aspart 30, insulin detemir, and insulin aspart. METHODS: Korean type 2 diabetes patients who have not been treated with the study insulin or have started it within 4 weeks before enrollment were eligible for the study. The patient selection and the choice of regimen were at the discretion of the physician. The safety and efficacy information was collected from the subjects at baseline, week 12, and week 24. The number of serious adverse drug reactions (SADRs) was the primary endpoint. The changes of clinical diabetic markers at week 12 and/or at week 24 compared to baseline were the secondary endpoints. RESULTS: Out of 4,058 exposed patients, 3,003 completed the study. During the study period, three SADRs were reported in three patients (0.1%). No major hypoglycemic episodes were observed and the rate of minor hypoglycemic episodes marginally decreased during 24 weeks (from 2.77 to 2.42 events per patient-year). The overall quality of life score improved (from 66.7+/-15.9 to 72.5+/-13.5) while the mean body weight was slightly increased (0.6+/-3.0 kg). The 24-week reductions in glycated hemoglobin, fasting plasma glucose and postprandial plasma glucose were 1.6%+/-2.2%, 2.5+/-4.7 mmol/L, and 4.0+/-6.4 mmol/L, respectively. CONCLUSION: The studied regimens showed improvements in glycemic control with low incidence of SADRs, including no incidence of major hypoglycemic episodes in Korean patients with type 2 diabetes.
Biphasic Insulins
;
Body Weight
;
Diabetes Mellitus, Type 2
;
Drug Toxicity
;
Fasting
;
Glucose
;
Hemoglobins
;
Humans
;
Incidence
;
Insulin
;
Insulin Aspart
;
Insulin, Isophane
;
Insulin, Long-Acting
;
Patient Selection
;
Plasma
;
Quality of Life
;
Republic of Korea
;
Treatment Outcome
;
Insulin Detemir
5.Awareness of Korean dentists on bisphosphonate related osteonecrosis of the jaws : Preliminary report.
Yong Duck PARK ; Young Ran KIM ; Deog Yoon KIM ; Yoon Sok CHUNG ; Jeung Keun LEE ; Yeo Gab KIM ; Yong Dae KWON
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2009;35(3):153-157
Recently, an increasing number of bisphosphonate related osteonecrosis of the jaw(BRONJ) is being reported. A guideline has been already established in the US, but it does not seem to be fully recognized by clinicians in Korea. Therefore, a survey study was done to inform and have clinicians realize the seriousness of BRONJ. 1,341 practitioners were randomly selected out of 13,405 practitioners(by Feb of 2008, KDA) in Korea. A questionnaire was given to them between May to July in 2008. Questions were designed to investigate each respondent's experience term years in the clinic, occupation, speciality, awareness on risk of bisphosphonate, experience on treating osteonecrosis patients, awareness about the guideline on BRONJ suggested by AAOMS and whether if they ask about bisphosphonate medication history to patients before invasive treatment. 45.1% of the clinicians have reported on experiencing delayed healing on bone exposed site after extraction both in the maxilla and the mandible. However, clinicians have asked the patients whether if they are on bisphosphonate or not in only 15.1% of these cases. 56.5% of the clinicians simply knew about BRONJ but only 28.9% of the clinicians were aware that bisphosphonate can cause osteonecrosis after invasive dental treatment. Only 19.3% knew about the contents of guideline on BRONJ and 57.2% were aware of the seriousness of BRONJ. Clinicians with shorter clinical experience term were more aware of BRONJ and the guideline on BRONJ than the experienced clinicians. But awareness of the possibility of BRONJ after invasive dental treatment were about the same regardless of their clinical experience. The results show that Korean clinicians need to be more aware about BRONJ. Data on BRONJ cases in Korea should be collected and provided with additional education to let Korean clinicians know and be more aware about BRONJ
Bisphosphonate-Associated Osteonecrosis of the Jaw
;
Dentists
;
Humans
;
Korea
;
Linear Energy Transfer
;
Mandible
;
Maxilla
;
Occupations
;
Osteonecrosis
;
Surveys and Questionnaires
6.A Global Gene Expression Analysis of the Peripheral Blood Mononuclear Cells Reveals the Gene Expression Signature in Psoriasis.
Sang Keun LEE ; Eun Kyoung JEON ; Yu Jin KIM ; Sam Hwa SEO ; Chang Deok KIM ; Jong Soon LIM ; Jeung Hoon LEE
Annals of Dermatology 2009;21(3):237-242
BACKGROUND: Psoriasis is a chronic inflammatory skin disease that affects approximately 1~3% of the general population. OBJECTIVE: We performed cDNA microarray analysis with using the dendrimer labelling method to investigate the gene expression profile in the peripheral blood mononuclear cells (PBMCs) of psoriatic patients. METHODS: The peripheral blood mononuclear cells of 5 patients with psoriasis and 8 control subjects were used in the gene expression analyses of psoriasis. RESULTS: We identified 212 differentially expressed genes that showed at least a two-fold induction and/or reduction in psoriatic patients. Among those, 63 genes, including CD44, CD56 and IL7R, were induced, while 139 genes, including the sphingosine kinase 1 and p16-INK genes, were reduced in the psoriatic patients. CONCLUSION: We can speculate that these genes may have a role for the pathogenesis of psoriasis via their affecting different cellular functions. Our results suggest a possible mechanism by which activated immune cells migrate from the blood to the skin in psoriatic patients, and we provide novel putative targets for developing drugs to treat psoriasis
Cell Adhesion
;
Dendrimers
;
Gene Expression
;
Humans
;
Oligonucleotide Array Sequence Analysis
;
Phosphotransferases
;
Phosphotransferases (Alcohol Group Acceptor)
;
Psoriasis
;
Skin
;
Skin Diseases
;
Sphingosine
;
Transcriptome
7.A Retrospective Study of the Radiotherapy Care Patterns for Patients with Laryngeal Cancer and Comparison of Different Korean Hospitals Treated from 1998 through 1999.
Woong Ki CHUNG ; Il Han KIM ; Mee Sun YOON ; Sung Ja AHN ; Taek Keun NAM ; Ju Young SONG ; Jae Uk CHUNG ; Byung Sik NAH ; Joon Kyoo LEE ; Hong Gyun WU ; Chang Geol LEE ; Sang Wook LEE ; Won PARK ; Yong Chan AHN ; Ki Moon KANG ; Jung Soo KIM ; Yoon Kyeong OH ; Moon June CHO ; Woo Yoon PARK ; Jin Hee KIM ; Doo Ho CHOI ; Hyong Geun YUN ; Woo Cheol KIM ; Dae Sik YANG ; Seung Chang SOHN ; Hyun Suk SUH ; Ki Jung AHN ; Mison CHUN ; Kyu Chan LEE ; Young Min CHOI ; Tae Sik JEUNG ; Jin Oh KANG
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2009;27(4):201-209
PURPOSE: To investigate the care patterns for radiation therapy and to determine inter-hospital differences for patients with laryngeal carcinoma in Korea. MATERIALS AND METHODS: A total of 237 cases of laryngeal carcinoma (glottis, 144; supraglottis, 93) assembled from 23 hospitals, who underwent irradiation in the year of 1998 and 1999, were retrospectively analyzed to investigate inter-hospital differences with respect to radiotherapy treatment. We grouped the 23 hospitals based on the number of new patients annually irradiated in 1998; and designated them as group A (> or =900 patients), group B (> or =400 patients and <900 patients), and group C (<400 patients). RESULTS: The median age of the 237 patients was 62 years (range, 25 to 88 years), of which 216 were male and 21 were female. The clinical stages were distributed as follows: for glottis cancer, I; 61.8%, II; 21.5%, III; 4.2%, IVa; 11.1%, IVb; 1.4%, and in supraglottic cancer, I; 4.3%, II; 19.4%, III; 28.0%, IVa; 43.0%, IVb; 5.4%, respectively. Some differences were observed among the 3 groups with respect to the dose calculation method, radiation energy, field arrangement, and use of an immobilization device. No significant difference among 3 hospital groups was observed with respect to treatment modality, irradiation volume, and median total dose delivered to the primary site. CONCLUSION: This study revealed that radiotherapy process and patterns of care are relatively uniform in laryngeal cancer patients in Korean hospitals, and we hope this nationwide data can be used as a basis for the standardization of radiotherapy for the treatment of laryngeal cancer.
Female
;
Glottis
;
Humans
;
Immobilization
;
Korea
;
Laryngeal Neoplasms
;
Male
;
Retrospective Studies
8.Expression of Neutrophil Gelatinase-Associated Lipocalin in Calcium-Induced Keratinocyte Differentiation.
Jeung Hoon LEE ; Kyung Chae KYE ; Eun Young SEO ; Kyungmoon LEE ; Sang Keun LEE ; Jong Soon LIM ; Young Joon SEO ; Chang Deok KIM ; Jang Kyu PARK
Journal of Korean Medical Science 2008;23(2):302-306
In a previous search for the differentially expressed genes in keratinocyte differentiation, we identified neutrophil gelatinase-associated lipocalin (NGAL) as a calcium- induced gene. In this study, we further verified the expression of NGAL in cultured keratinocytes as well as in several skin diseases. Reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and ELISA clearly showed that NGAL expression was markedly increased in calcium-induced keratinocyte differentiation in vitro. However, in our previous report, NGAL expression was not detected in normal skin tissue except for hair follicle by in situ hybridization and immunohistochemistry, indicating the difference of cell status between in vitro and in vitro conditions. Interestingly, NGAL expression was highly increased in psoriasis-like inflammatory disorders (lichen planus and pityriasis rubura pilaris) and skin cancers (keratoacanthoma and squamous cell carcinoma), implying that NGAL may be related with the epidermal hyperplasia. Collectively, these results reveal the potential importance of NGAL in the maintenance of skin homeostasis.
Acute-Phase Proteins/*biosynthesis
;
Calcium/*metabolism
;
Cell Differentiation
;
Culture Media
;
Culture Media, Conditioned
;
Enzyme-Linked Immunosorbent Assay
;
*Gene Expression Regulation
;
Homeostasis
;
Humans
;
Keratinocytes/enzymology
;
Lipocalins/*biosynthesis
;
Models, Biological
;
Proto-Oncogene Proteins/*biosynthesis
;
Psoriasis/enzymology
;
Reverse Transcriptase Polymerase Chain Reaction
;
Skin/*metabolism
;
Skin Neoplasms/enzymology
9.Mass-forming focal-type autoimmune pancreatitis difficult to differentiate from pancreatic cancer.
Jae Keun LEE ; Myung Hwan KIM ; Jeung Hye HAN ; Tae Yoon LEE ; Sang Su LEE ; Dong Wan SEO ; Sung Koo LEE
Korean Journal of Medicine 2008;74(6):667-671
Autoimmune chronic pancreatitis (AIP) typically manifests as diffuse pancreatic swelling and diffuse irregular narrowing of the main pancreatic duct. Recently, mass-forming focal-type AIP, which shows focal pancreatic swelling with mass and focal narrowing of the main pancreatic duct, has been reported. Since this type of AIP is difficult to differentiate from pancreatic cancer, the greater part of these cases have been treated surgically, with the diagnosis confirmed thereafter. Here we report a case of mass-forming focal-type AIP detected in the head of the pancreas; it has been successfully treated with steroids.
Head
;
Pancreatic Ducts
;
Pancreatic Neoplasms
;
Pancreatitis
;
Pancreatitis, Chronic
10.A Study of the Results of Patch Test in Patients with Contact Dermatitis.
Ga Young LEE ; Jung Keun KIM ; Kea Jeung KIM
Korean Journal of Dermatology 2007;45(9):908-914
BACKGROUND: More than 10 years have passed since the second multicenter study on standard patch test were carried out in Korea (1986-1993) and an update is needed. OBJECTIVE: The purpose of this study was to analyze the type, frequency and changes of the common contact allergens in Korea. METHODS: Standard patch tests were performed using Finn chamber on Scanpor tape on in-patients and out-patients with contact dermatitis from January 2000 to July 2006. Epidemiologic findings of patients and the results of the patch tests were analyzed. RESULTS: A total of 528 patch tested cases (male 135, female 393) were compiled and analyzed. The highest age distribution was 5th decade in males and 3rd decade in females. Patients' employment background showed that housewives and office-workers were the most frequently expected jobs consisting 32.4% and 15.2% respectively. The face, including eyelid and lip, was the most frequently affected site comprising 61.2%. The highest sensitization rates were found with : nickel (31.1%), neomycin (9.3%), cobalt (6.4%) and potassium (6.3%). The lowest positivity included : Me-Cl-Isothiazolinone (0.4%), 7-mercaptobenzothiazole (0.8%), black rubber mix (0.8%) and wool alcohol (0.8%). While nickel and neomycin showed increased reacitivities, formaldehyde, fragrance mix and colophony showed a decreased tendency when compared with those of other previous studies. CONCLUSION: These results provide the basis for the presumption of the route of allergen exposure and prevention of contact dermatitis in Korea.
Age Distribution
;
Allergens
;
Cobalt
;
Dermatitis, Contact*
;
Employment
;
Eyelids
;
Female
;
Formaldehyde
;
Humans
;
Korea
;
Lip
;
Male
;
Neomycin
;
Nickel
;
Outpatients
;
Patch Tests*
;
Potassium
;
Rubber
;
Wool

Result Analysis
Print
Save
E-mail